Type:Term

A

• ARDS
• Abatement
• Abdominal pain
• Abscess
• Absorbed Dose
• Absorption
• Absorption barrier
• Acceptable Daily Intake (ADI)
• Accuracy
• Acidosis
• Acidosis, lactic
• Acidosis, renal tubular
• Acne
• Acneiform eruption
• Action levels
• Acute
• Acute Reference Dose (RfD)
• Acute contact toxicity test (honeybees)
• Acute exposure
• Acute oral toxicity
• Acute oral toxicity test (honeybees)
• Acute reference concentration (arfc)
• Acute toxic class method
• Acute toxicity
• Acute toxicity (daphnia)
• Acute toxicity (dermal irritation/corrosion)
• Acute toxicity (dermal)
• Acute toxicity (eye irritation/corrosion)
• Acute toxicity (fish)
• Acute toxicity (inhalation)
• Acute toxicity (skin sensitization)
• Acute toxicity - fixed dose procedure
• Added (additional) risk
• Addiction
• Additional Risk (AR)
• Adme
• Administered dose
• Adrenal insufficiency
• Adsorption
• Adverse ecological effects
• Adverse effect
• Aerodynamic diameter
• Aerosol
• Aggregate risk
• Aggression
• Agoraphobia
• Agranulocytosis
• Air monitoring
• Air pollutant
• Air pollution
• Air quality criteria
• Air quality standards
• Airborne particulates
• Akathisia, drug-induced
• Akinesia
• Akinetic mutism
• Albuminuria
• Allergic contact dermatitis
• Allergic reaction
• Alopecia
• Amblyopia
• Amenorrhea
• Amnesia
• Analysis
• Anaphylaxis
• Anecdotal data
• Anemia

A cont.

• Anemia, aplastic
• Anemia, hemolytic
• Anemia, macrocytic
• Anemia, megaloblastic
• Anemia, sideroblastic
• Angioedema
• Antagonism
• Anuria
• Anxiety
• Apathy
• Aphasia
• Apnea
• Appetite depressants
• Applied dose
• Apraxia
• Arachnoiditis
• Areflexia
• Arrhythmias, cardiac
• Arthralgia
• Arthritis
• Arthropathy
• Ascites
• Aseptic meningitis
• Aspiration pneumonia
• Assessment
• Assessment endpoint
• Assessment factor
• Asthenia
• Asthma
• Ataxia
• Atrial flutter
• Atrioventricular block
• Attributable risk
• Average daily dose

B

• Back pain
• Background level
• Bacterial infection
• Baseline risk assessment
• Behavioral symptoms
• Benchmark Dose (BMD) or Concentration (BMC)
• Benchmark Response (BMR)
• Benefit
• Best Available Control Measures (BACM)
• Best Available Control Technology (BACT)
• Best Demonstrated Available Technology (BDAT)
• Best Management Practice (BMP)
• Bias
• Bioaccumulation
• Bioassay
• Bioavailability
• Bioconcentration
• Biologic indicator
• Biologic monitoring
• Biological control
• Biological half life
• Biological magnification
• Biomarker
• Biota
• Biotransformation
• Bipolar Disorder
• Blepharitis
• Blepharospasm
• Blindness
• Blisters
• Bloating
• Body burden
• Bone marrow suppression
• Bone pain

B cont.

• Bounding estimate
• Bradycardia
• Bradypnea
• Bronchiolitis obliterans
• Bronchitis
• Bronchoconstriction
• Bullous dermatosis
• Bullous pemphigoid
• Bundle-branch block
• Burns

C

• CAS (Chemical Abstracts Service registry number)
• CERCLA (Comprehensive Environmental Restoration and Compensation Liability Act)
• Cancer
• Cancer risk (inhalation)
• Cancer risk (oral)
• Capillary leak syndrome
• Carcinogen
• Carcinogenesis
• Carcinogenic
• Carcinogenic potency
• Carcinogenic risk
• Cardiac tamponade
• Cardiogenic shock
• Cardiomegaly
• Cardiomyopathy
• Cardiomyopathy, dilated
• Cardiotoxins
• Carpal tunnel syndrome
• Case-control study
• Case-fatality rate
• Cataract
• Catatonia
• Cauda equina syndrome
• Cellulitis
• Cerebellar Ataxia
• Cerebral edema
• Cerebral hemorrhage
• Cerebral infarction
• Cerebral ischemia
• Cerebral vasculitis
• Chemical-specific adjustment factor (CSAF)
• Chestpain
• Chills
• Cholangitis
• Cholecystitis
• Cholestasis
• Cholestatic jaundice
• Chorea
• Choreoathetosis
• Chronic
• Chronic effect
• Chronic exposure
• Chronic fatigue syndrome
• Chronic hazard or toxicity
• Chronic study (Chronic exposure)
• Churg-Strauss syndrome
• Cirrhosis
• Cleanup
• Cleft palate
• Coagulopathy
• Coefficient of haze
• Cohort study
• Colic
• Colitis
• Coma